scholarly journals Economic burden of main Noncommunicable diseases in the Russian Federation in 2016

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
A Kontsevaya ◽  
Y Balanova ◽  
M Khudyakov ◽  
A Myrzamatova ◽  
D Mukaneeva ◽  
...  
Keyword(s):  
Health Care ◽  
Russian Federation ◽  
Economic Burden ◽  
Indirect Costs ◽  
Premature Death ◽  
Direct Costs ◽  
Noncommunicable Diseases ◽  
Economic Losses ◽  
Years Of Life Lost ◽  
The Russian Federation

Abstract Aim To estimate the economic burden of noncommunicable diseases (NCDs) in the Russian Federation (RF) in 2016, including the direct costs and the economic losses caused by reduced productivity. Material and Methods We included 4 diseases: cardiovascular, type 2 diabetes, cancer and chronic pulmonary disease (COPD). We used the official statistics data collected by Ministry of health on the number of patients, health care resources utilization (hospitalizations, emergency visits, outpatients’ visits). The costs of health care were obtained from health insurance fund. Directs nonmedical costs included disabilitypayments, calculated based on the number of disabled persons from each group and by the amount of the disability allowance. Indirect costs (economic losses) included decreased productivity due to premature mortality and disability. The potential years of life lost (PYLL) were calculated using the number of life years lost due todeath and disability due to NCDs before 70 years. Human capital approach was used, and calculation were based on the GDP per person. Results Number of PYLL due to premature death from NCDs was estimated to be 8,0 million years. Economic burden because of NCDs in 2016 in the RF reached 3,3 trillion (45.9 billion €), which is equivalent of 3.9% of GDP for this year. Direct costs were responsible only for 13% of losses, indirect costs for 87% of the total burden. CVD were responsible for 81,4% of burden, cancer – for 7,1%, diabetes - 6,5% and COPD for 5,0%. Conclusions The economic burden because of NCDs in the RF in 2016 was 3.3 trillion (3.9% of GDP). Such the significant economic burden and absence of positive dynamics is a strong argument for increasing investments in the prevention and treatment of NCDs. Key messages Number of PYLL due to premature death from NCDs was estimated to be 8,0 million years. Economic burden because of NCDs in 2016 in the RF reached 3,3 trillion (45.9 billion €), which is equivalent of 3.9% of GDP for this year.

scholarly journals The Economic Burden of Cancers Attributable to Infection in the Republic of Korea: A Prevalence-Based Study

2020 ◽  
Vol 17 (20) ◽  
pp. 7592
Author(s):  
Thi Xuan Trinh Nguyen ◽  
Minji Han ◽  
Moran Ki ◽  
Young Ae Kim ◽  
Jin-Kyoung Oh
Keyword(s):  
Cancer Patients ◽  
Economic Burden ◽  
Productivity Loss ◽  
Population Attributable Fraction ◽  
Indirect Costs ◽  
Premature Death ◽  
Direct Costs ◽  
Income Loss ◽  
Future Income ◽  
The Republic

Infection is a major cause of cancers. We estimated the economic burden of cancers attributable to infection in 2014 in Korea, where cancer causing infection is prevalent, but the economic burden of it has never been examined. Cancer patients were defined as those having made medical claims as recorded by the National Health Insurance Service, which is a mandatory insurance for all citizen. We multiplied the costs by the population-attributable fraction for each type of cancer. The study included direct and indirect costs, where direct costs comprised direct medical and non-medical costs of inpatients and outpatients, while indirect costs were estimated by identifying future income loss due to premature death, productivity loss during hospitalization/outpatient visits, and job loss. In 2014, there were 100,054 infection-related cancer patients, accounting for 10.7% of all Korean cancer cases for that year. Direct costs of cancers associated with infection stood at nearly USD 676.9 million, while indirect costs were much higher at USD 2.57 billion. The average expenditure of a typical patient was USD 32,435. Economic burden of cancers attributable to infection is substantial in Korea, accounting for 0.23% of the national gross domestic product and 1.36% of national healthcare expenditure in 2014.

Economic burden of noncommunicable diseases attributable to risk factors in the Russian Federation

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
A Kontsevaya ◽  
A Myrzamatova ◽  
D Mukaneeva ◽  
Y u Balanova ◽  
M Khudyakov ◽  
...  
Keyword(s):  
Risk Factors ◽  
Russian Federation ◽  
Economic Burden ◽  
Alcohol Intake ◽  
Noncommunicable Diseases ◽  
High Alcohol ◽  
Strong Argument ◽  
Prevention And Treatment ◽  
The Russian Federation ◽  
High Alcohol Intake

Abstract Aim to estimate the economic burden of major chronic noncommunicable diseases (NCDs) attributable to risk factors in the Russian Federation in 2016 Material and Methods The following risk factors were included in the analysis: smoking, high alcohol intake, high salt intake, low intake of fresh vegetables and fruits, consumption of processed red meat, low physical activity, obesity, hypertension, which reliably have a causal relationship with major NCDs: cardiovascular diseases(CVD),type 2 diabetes, chronic obstructive pulmonary disease(COPD), cancer of 10 localizations. The relative risks (RR)of morbidity and mortality from major NCDs associated with risk factors are identified through a literature search. Based on the data on the prevalence of risk factors in the Russian population and RR, the population attributable risk (PAR)was calculated for each analyzed disease. Statistical analysis calculations using descriptive statistics methods were performed in the MSExcel 10.0 program. Results The largest burden from the four main NCDs is associated with hypertension - 10.9 billion€, which is equivalent to 1.01% of GDP. The next largest contribution to the burden from NCDs was the burden from obesity 7.6 billion€ 0.7% of GDP, smoking over 5.2 billion €, 0.49% of GDP and the low physical activity 3.4 billion€, 0.32% of GDP. Of all the analyzed risk factors, the least contribution to total costs in connection with NCDs was determined by the burden from high alcohol intake 1.1 billion€, 0.1% of GDP, due to the low prevalence of high alcohol intake in the Russian population. Conclusions In this study, for the first time, the assessment of the economic burden of risk factors by the share (contribution) to the morbidity and mortality of main NCDs (CVD, T2DM, COPD and 10 cancer localizations) in the Russian Federation for 2016 was performed. Such the significant economic burden is a strong argument for increasing investments in the prevention and treatment of risk factors of NCDs. Key messages In Russia the largest burden from the four main NCDs is associated with hypertension. Such the significant economic burden is a strong argument for increasing investments in the prevention and treatment of risk factors of NCDs.

scholarly journals Pharmacoeconomic aspects of bronchial asthma therapy: real clinical practice

2018 ◽  
pp. 60-68 ◽  
Author(s):  
A. S. Belevsky ◽  
A. A. Zaitsev
Keyword(s):  
Russian Federation ◽  
Indirect Costs ◽  
Direct Costs ◽  
Gross Regional Product ◽  
Permanent Disability ◽  
Alternative Drug ◽  
The Russian Federation ◽  
Socioeconomic Burden ◽  
Regional Product ◽  
The Cost

According to official statistics, over 1.5 million people have BA in the Russian Federation. Direct costs associated with the treatment of BA in the Russian Federation amount to 8.5 billion rubles. The socioeconomic burden of BA put on society, along with temporary and permanent disability, is caused by not only direct, but also indirect costs, as well as costs associated with payments for temporary disability, which leads to a decrease in GDP and GRP (internal gross regional product). The pharmacoeconomic comparison of two alternative drug technologies in the studied groups showed a reasonable opportunity to transfer patients to the drugs that have alternatives produced within the country, confirming that the cost per efficiency unit in using Formisonide-Native and SalticasoneNative is lower than that of drugs produced by a foreign pharmaceutical company (Symbicort Turbuhaler and Seretide Multidisk)

scholarly journals The burden attributable to substance use in the Russian Federation

2020 ◽  
Vol LII (1) ◽  
pp. 49-54
Author(s):  
Sergej S. Soshnikov ◽  
Vladimir I. Starodubov ◽  
Dar’ya A. Khaltourina ◽  
Vasilij V. Vlassov ◽  
Ol’ga V. Obuhova ◽  
...  
Keyword(s):  
Substance Use ◽  
Russian Federation ◽  
Alcoholic Cirrhosis ◽  
Economic Assessment ◽  
Economic Losses ◽  
Years Of Life Lost ◽  
Psychoactive Substances ◽  
The World ◽  
The Russian Federation ◽  
The Impact

Aim. Assessment of the health consequences of substance use in the form of lost years of healthy life in the world in comparison with Russia. An additional task was to determine the economic losses from alcohol, tobacco and drugs in the Russian Federation. Methods. We used indicators of mortality, morbidity, prevalence, and years of life lost, taking into account the DALY disability from tobacco, alcohol, opiates, cannabis, and other drugs (ICD10: I42.6, K70.03, Z72.0, F10-19). Indicators of harmful health effects from PS were presented from 1990 to 2017. Variables were standardized by age and sex. An economic assessment of the impact of tobacco, alcohol, and drugs denominated in rubles was applied. Results. Total economic losses from psychoactive substances, expressed in rubles, amounted to from 887.4 billion to 8.5 trillion rubles in Russia in 2017. The greatest harmful effects on health from psychoactive substances in Russia and the world are caused by tobacco, with alcohol in the second place. The damage from smoking in Russia in years of lost life including disability DALY amounted to 8.6 million in 2017 Alcohol consumption and its consequences in Russia caused 1.85 million DALYs of harm to health, alcoholic cirrhosis and other liver diseases-643 thousand DALYs. Conclusion. Alcohol and nicotine cause maximum harm to the health and economy of Russia, and in conditions of limited resources, the main efforts should be directed at preventing the consequences of alcoholism and tobacco smoking.

SKIN DISEASES CAUSED BY ULTRAVIOLET RADIATION: THE COST OF ILLNESS

2003 ◽  
Vol 19 (4) ◽  
pp. 724-730 ◽  
Author(s):  
Gunnar H. Nilsson ◽  
Lennart Carlsson ◽  
Henrik Dal ◽  
Henrik Ullén
Keyword(s):  
Health Care ◽  
Ultraviolet Radiation ◽  
Cost Of Illness ◽  
Hospital Care ◽  
Skin Diseases ◽  
Indirect Costs ◽  
Direct Costs ◽  
Economic Losses ◽  
Discounted Cost ◽  
Care Costs

Objectives: To assess the annual direct and indirect costs of skin diseases caused by ultraviolet radiation.Methods: A model for cost-of-illness, including costs for hospital care, primary care, pharmaceuticals, mortality, and morbidity, for approximately 1.8 million inhabitants in Stockholm.Results: The total annual discounted cost-of-illness in Stockholm was approximately 162 million SEK (MSEK; approximate 2002 exchange rate: 1 U.S. dollar=10 SEK). The indirect costs were predominant and constituted approximately 91 MSEK (56% of total costs), mainly due to an estimated cost of mortality for cutaneous malignant melanoma of 84 MSEK. The direct costs of these diseases, approximately 71 MSEK, were predominated by hospital ambulatory care costs of approximately 33 MSEK. The direct costs constituted approximately 0.4% of the overall health-care costs for hospital care and primary health care in the area.Conclusions: Skin diseases caused by ultraviolet radiation result in moderate economic losses in the community. Therefore, it may not be easy to make successful prevention of these diseases economically beneficial.

Estimation of Socioeconomic Burden of Lung Cancer in the Russian Federation

2018 ◽  
pp. 63-75 ◽  
Author(s):  
Maria Avxentyeva ◽  
Filipp Gorkavenko ◽  
Anna Nikitina ◽  
Anastasia Savilova ◽  
Ksenia Gerasimova ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Russian Federation ◽  
Economic Burden ◽  
Indirect Costs ◽  
Medical Costs ◽  
Newly Diagnosed ◽  
Friction Cost ◽  
The Russian Federation ◽  
Friction Cost Method ◽  
The Impact

The aim of this study was to estimate the socio-economic burden of lung cancer (LC) in the Russian Federation. Methodology: the social burden of LC is defined as the number of patients newly diagnosed with LC in 2016, those who are followed-up in oncology clinics, disabled and deceased persons. The economic burden consists of total direct and indirect costs associated with LC and estimated from a government perspective. Direct medical costs include costs for diagnosis, inpatient and outpatient treatment, palliative care, follow-up costs, and expenditures for the subsidized drug coverage. Direct non-medical costs include payments for sickness and disability caused by LC. Indirect costs were calculated as a loss of a gross domestic product due to LC morbidity and mortality. Calculations were based on the methods described in Ignatieva V. I. et al. (2014) and adapted by the authors of this study to new methods of inpatient medical care payment. Indirect costs were calculated by the friction cost method. The sensitivity analysis was conducted to estimate the impact of initial parameters` variations, as well as the impact of indirect costs estimation with the human capital methods, on the results. Results. In 2016, medical care was provided to 185,631 patients with LC, of whom 51,768 (27.9%) were newly diagnosed during the year. Direct medical costs were about 6.83 billion rubles. Most costs were incurred in inpatient care (4.09 billion rubles, 60.0%) and for the subsidized drug coverage (1.49 billion rubles, 21.8%). Direct non-medical expenses were about 5.76 billion rubles, 5.16 billion (89.7%) were disability-related payments. Indirect costs were about 14.77 billion rubles (friction cost method).

Issues of co-financing of drug provision for the population: international and Russian practice

2020 ◽  
pp. 49-56
Author(s):  
Vasiliy Ryazhenov ◽  
Victoriya Andreyeva ◽  
Elena Zakharochkina
Keyword(s):  
Health Care ◽  
Life Expectancy ◽  
Health System ◽  
Health Care System ◽  
Russian Federation ◽  
High Quality ◽  
Russian President ◽  
The Russian Federation ◽  
Vladimir Putin ◽  
Drug Provision

Russian President Vladimir Putin defined increase in life expectancy from 72.7 to 78 years by 2024 as a national aim in the Decree № 204 of May 7, 2018. Achievement of this aim depends on drug provision system among other factors. Strategy of drug provision for the population of the Russian Federation for the period until 2025 sets the goal of increasing availability of high quality, effective and safe medicines to meet needs of the population and the health system based on the formation of a rational and balanced system of drug provision for the population of the country with available resources. The health care system should expand the possibilities of using modern and effective mechanisms to ensure the financing of drug provision for the population.

Organization of the control system for realization of the National project «Health care» by Roszdravnadzor

2019 ◽  
Vol 2019 (4) ◽  
pp. 5-12 ◽  
Author(s):  
Михаил Мурашко ◽  
Mihail Murashko ◽  
Ирина Серегина ◽  
Irina Seregina
Keyword(s):  
Health Care ◽  
Control System ◽  
Russian Federation ◽  
State Control ◽  
Risk Of Falling ◽  
National Project ◽  
Department Of State ◽  
The Russian Federation ◽  
Control And Monitoring System ◽  
Regional Projects

The article presents main properties of the federal projects of the National project «Health care», as well as the main activities of those projects, in which Roszdravnadzor has a particular interest. The article depicts the control and monitoring system applied by the Department of state control of implementation of state healthcare programs of Rosdravnadzor, which allows to detect in real time the subjects of the Russian Federation that have the highest risk of falling short of the targeted indicator of the regional projects and to take this information into account during the development of the plan for the control and surveillance activities.

CRIMINAL LEGAL MEANS OF PROVIDING HEALTH CARE DURING THE COVID-19 PANDEMIC

2020 ◽  
Vol 10 (6) ◽  
pp. 31-41
Author(s):  
DANILA ILIN ◽  
Keyword(s):  
Health Care ◽  
Law Enforcement ◽  
Health System ◽  
Russian Federation ◽  
Criminal Law ◽  
Social Life ◽  
Criminal Liability ◽  
General Description ◽  
Theoretical Approaches ◽  
The Russian Federation

The article presents the results of a study of the problems of criminal legal assessment of criminal attacks on the health care system during the COVID-19 pandemic. The social background of such crime and its criminological characteristics are studied. Given the fact that most of criminal law, aimed at preventing crime, reducing the capacity of the state in the fight against novel coronavirus infection treated in depth by the legal and regulatory framework is impeding the spread of the pandemic COVID-19, and analyzed Federal laws, decrees of the President of the Russian Federation, decisions and orders of the Government of the Russian Federation, orders of the Ministry of health of Russia and other state bodies governing the functioning of public authorities, medical institutions and organizations, the rights and obligations of citizens and legal entities, this includes measures for the prevention of this disease in various areas of social life that are additionally regulated during the COVID-19 pandemic. The task of optimizing the criminal law provision of health care during the COVID-19 pandemic is formulated, taking into account the actual situation with the spread of this infection and the practice of countering it. As part of this task, based on a critical analysis of existing approaches in the science of criminal law, we formulate our own concept of crimes that infringe on the health system during the COVID-19 pandemic, characterize the problem, study their legal and social nature, and systematize such crimes. On the basis of the obtained data, a General description of crimes that encroach on the health system during the COVID-19 pandemic is given, their criminal-legal features are considered, theoretical approaches to determining their essence are studied, and the author's position on this issue is formulated. The author's classification of crimes that hinder the provision of health care during the COVID-19 pandemic is given. Groups of such crimes are consistently considered. A General description of their objective and subjective characteristics is given. Proposals for improving the interpretation of the relevant criminal law norms in science and law enforcement practice have been developed, and suggestions for their improvement have been substantiated and formulated. The article is addressed not only to scientists and practitioners of law enforcement agencies, but also to doctors who often work in conditions of a lack of legal knowledge about their rights and obligations, the qualification of certain acts from the point of view of criminal law, the grounds and limits of criminal liability for those that constitute a crime, and algorithms for actions in case of detection of such acts.

Sign in / Sign up

Export Citation Format

Share Document